These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30995439)

  • 1. Fractional turnover of apolipoprotein(a) and apolipoprotein B-100 within plasma lipoprotein(a) particles in statin-treated patients with elevated and normal Lp(a) concentration.
    Ma L; Chan DC; Ooi EMM; Barrett PHR; Watts GF
    Metabolism; 2019 Jul; 96():8-11. PubMed ID: 30995439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a).
    Watts GF; Chan DC; Pang J; Ma L; Ying Q; Aggarwal S; Marcovina SM; Barrett PHR
    Metabolism; 2020 Jun; 107():154221. PubMed ID: 32240727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma Lipoprotein(a) Concentration.
    Ma L; Chan DC; Ooi EMM; Marcovina SM; Barrett PHR; Watts GF
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6247-6255. PubMed ID: 31393573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).
    Diffenderfer MR; Lamon-Fava S; Marcovina SM; Barrett PH; Lel J; Dolnikowski GG; Berglund L; Schaefer EJ
    Metabolism; 2016 Apr; 65(4):381-90. PubMed ID: 26975530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.
    Jenner JL; Seman LJ; Millar JS; Lamon-Fava S; Welty FK; Dolnikowski GG; Marcovina SM; Lichtenstein AH; Barrett PH; deLuca C; Schaefer EJ
    Metabolism; 2005 Mar; 54(3):361-9. PubMed ID: 15736114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy.
    Chan DC; Watts GF; Coll B; Wasserman SM; Marcovina SM; Barrett PHR
    J Am Heart Assoc; 2019 Apr; 8(7):e011781. PubMed ID: 30897995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
    Merki E; Graham MJ; Mullick AE; Miller ER; Crooke RM; Pitas RE; Witztum JL; Tsimikas S
    Circulation; 2008 Aug; 118(7):743-53. PubMed ID: 18663084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease.
    Ma L; Waldmann E; Ooi EMM; Chan DC; Barrett HPR; Watts GF; Parhofer KG
    Eur J Clin Invest; 2019 Feb; 49(2):e13053. PubMed ID: 30447089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients.
    Frischmann ME; Kronenberg F; Trenkwalder E; Schaefer JR; Schweer H; Dieplinger B; Koenig P; Ikewaki K; Dieplinger H
    Kidney Int; 2007 May; 71(10):1036-43. PubMed ID: 17299521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics.
    Watts GF; Chan DC; Somaratne R; Wasserman SM; Scott R; Marcovina SM; Barrett PHR
    Eur Heart J; 2018 Jul; 39(27):2577-2585. PubMed ID: 29566128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a).
    Yeang C; Hung MY; Byun YS; Clopton P; Yang X; Witztum JL; Tsimikas S
    J Clin Lipidol; 2016; 10(3):594-603. PubMed ID: 27206947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a).
    Frischmann ME; Ikewaki K; Trenkwalder E; Lamina C; Dieplinger B; Soufi M; Schweer H; Schaefer JR; König P; Kronenberg F; Dieplinger H
    Atherosclerosis; 2012 Dec; 225(2):322-7. PubMed ID: 23099120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion.
    Youssef A; Clark JR; Marcovina SM; Boffa MB; Koschinsky ML
    Arterioscler Thromb Vasc Biol; 2022 Mar; 42(3):289-304. PubMed ID: 35045727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men.
    Chan DC; Watts GF; Wang J; Hegele RA; van Bockxmeer FM; Barrett PH
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):45-51. PubMed ID: 18031309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin-treated patients with very high apolipoprotein(a) concentration.
    Ying Q; Chan DC; Pang J; Marcovina SM; Barrett PHR; Watts GF
    J Intern Med; 2022 Jun; 291(6):870-876. PubMed ID: 35112754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of niacin on triglyceride-rich lipoprotein apolipoprotein B-48 kinetics in statin-treated patients with type 2 diabetes.
    Pang J; Chan DC; Hamilton SJ; Tenneti VS; Watts GF; Barrett PH
    Diabetes Obes Metab; 2016 Apr; 18(4):384-91. PubMed ID: 26679079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a).
    Clark JR; Gemin M; Youssef A; Marcovina SM; Prat A; Seidah NG; Hegele RA; Boffa MB; Koschinsky ML
    J Lipid Res; 2022 Jun; 63(6):100216. PubMed ID: 35469919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of apo[a] and apoB in human atherosclerotic lesions.
    Pepin JM; O'Neil JA; Hoff HF
    J Lipid Res; 1991 Feb; 32(2):317-27. PubMed ID: 1829751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypobetalipoproteinemia is not associated with low levels of lipoprotein(a).
    Averna M; Marcovina SM; Noto D; Cole TG; Krul ES; Schonfeld G
    Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2165-75. PubMed ID: 7489238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.